Chang‐Il Hwang
- Molecular Biology top 10%
- Cancer Research top 5%
- Oncology top 5%
- Immunology
- Reproductive Medicine top 5%
- Co-authors
- Alexander Yu. NikitinAndrea Flesken‐NikitinChieh-Yang ChengGrigori EnikolopovTatyana V. MichurinaDavid C. CorneyHeiko HermekingDavid A. Tuveson
- Topics
- Pancreatic and Hepatic Oncology Research (11 papers)Epigenetics and DNA Methylation (8 papers)Cancer Cells and Metastasis (6 papers)
- Partner nations
- United StatesSouth KoreaUnited Kingdom
In The Last Decade
Chang‐Il Hwang
33 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 94
- Molecular Biology 936
- Cancer Research 589
- Oncology 559
- Immunology 202
- Reproductive Medicine 142
Countries citing papers authored by Chang‐Il Hwang
This map shows the geographic impact of Chang‐Il Hwang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang‐Il Hwang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang‐Il Hwang more than expected).
Fields of papers citing papers by Chang‐Il Hwang
This network shows the impact of papers produced by Chang‐Il Hwang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang‐Il Hwang. The network helps show where Chang‐Il Hwang may publish in the future.
Co-authorship network of co-authors of Chang‐Il Hwang
This figure shows the co-authorship network connecting the top 25 collaborators of Chang‐Il Hwang. A scholar is included among the top collaborators of Chang‐Il Hwang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang‐Il Hwang. Chang‐Il Hwang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 11 | |
| 4 | 3 | |
| 5 | 5 | |
| 6 | 14 | |
| 7 | 14 | |
| 8 | 22 | |
| 9 | 89 | |
| 10 | 41 | |
| 11 | 82 | |
| 12 | 4 | |
| 13 | 20 | |
| 14 | 269 | |
| 15 | 58 | |
| 16 | 37 | |
| 17 | 39 | |
| 18 | 47 | |
| 19 | 97 | |
| 20 | 45 |
About Chang‐Il Hwang
Chang‐Il Hwang is a scholar working on Cancer Research, Oncology and Hepatology, having authored 34 papers that have together received 1.6k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (11 papers), Epigenetics and DNA Methylation (8 papers) and Cancer Cells and Metastasis (6 papers). The work is most often cited by research in Cancer Research (589 citations), Oncology (559 citations) and Reproductive Medicine (142 citations). Chang‐Il Hwang has collaborated with scholars based in United States, South Korea and United Kingdom. Frequent co-authors include Alexander Yu. Nikitin, Andrea Flesken‐Nikitin, Chieh-Yang Cheng, Grigori Enikolopov, Tatyana V. Michurina, David C. Corney, Heiko Hermeking, David A. Tuveson, Andrés Matoso and Woong‐Yang Park. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.